National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3) (PB 26 of 2019) (Cth)
PB 26 of 2019
National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 27 March 2019
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
_________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 3).
(2)This Instrument may also be cited as PB 26 of 2019.
Commencement
This Instrument commences on 1 April 2019.
Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
Schedule 1, after entry for Diphenoxylate with Atropine
insert:
| Dipyridamole with aspirin | Capsule 200 mg (sustained release)- 25 mg | Oral | Asasantin SR | 60 | 20.91 | 28.41 |
Schedule 1, entry for Levonorgestrel with Ethinylestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets [Brand: Levlen ED]
omit from the column headed “Claimed Price”: 8.71 substitute: 8.94
Schedule 1, entry for Levonorgestrel with Ethinylestradiol in the form Pack containing 6 tablets 50 micrograms- 30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets [Brand: Triquilar ED]
omit from the column headed “Claimed Price”: 17.79 substitute: 19.79
Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
omit from the column headed “Determined Price”: 3.45 substitute: 3.90
0
0
0